加仓中国：外资会买什么？

Summary of Key Points from Conference Call Industry or Company Involved - Focus on the Chinese manufacturing industry, particularly high-end manufacturing sectors such as renewable energy, chemicals, and pharmaceuticals [1][2][4] Core Insights and Arguments - Some segments of the Chinese manufacturing industry are facing financial challenges during their expansion phase, with deteriorating free cash flow and reduced ROIC, while WACC has turned negative [1][2] - Fiscal subsidies and a contraction in capital expenditure in 2024 are expected to improve free cash flow for certain export-advantaged manufacturing sectors [1][2] - Strengthening of anti-involution policies is anticipated to further repair the financial conditions of related industries, leading to a revaluation of their stock prices [1][2] - The Hang Seng Technology sector is expected to experience a major upward trend, transitioning from being driven solely by southbound capital to a dual-driven model involving both southbound and foreign capital [1][3] - The expectation of the Federal Reserve restarting interest rate cuts is likely to accelerate the return of global capital to China, providing stronger upward momentum for the Hang Seng Technology sector [1][3] Other Important but Possibly Overlooked Content - Investors are advised to focus on Chinese high-end manufacturing sectors with export competitive advantages, including renewable energy, chemicals, and pharmaceuticals [2][4] - Long-term investment strategies should consider three main lines: hard currency under de-globalization (such as gold and resources), hard technology (like AI computing and innovative pharmaceuticals), and Chinese advantageous manufacturing sectors under anti-involution policies, specifically in sub-sectors like photovoltaics, wind power equipment, lithium batteries, and fiberglass [1][4][5]